Advertisement
News
Advertisement

Molecular Insight files for Ch. 11

Fri, 12/10/2010 - 9:32am
Mass High Tech: The Journal of New England Technology

Molecular Insight Pharmaceuticals, Inc. has filed for chapter 11 bankruptcy protection, in a deal that will secure the company a $45 million cash infusion from a private investment company.

The Cambridge-based CEO Daniel Peters has resigned, as has Charles Abdalian, the chief financial officer, as part of the deal with San Francisco-based Savitr Capital LLC.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading